
CAS 910463-68-2
:Semaglutida
Descripción:
Semaglutida es un análogo sintético del péptido-1 similar al glucagón (GLP-1), utilizado principalmente en el manejo de la diabetes tipo 2 y la obesidad. Se caracteriza por su capacidad para aumentar la secreción de insulina en respuesta a niveles elevados de glucosa en sangre, ayudando así en el control glucémico. Semaglutida tiene una larga vida media debido a su resistencia a la degradación enzimática, lo que permite una administración subcutánea una vez a la semana. La sustancia se administra típicamente como una solución para inyección y es conocida por su eficacia en la promoción de la pérdida de peso además de sus efectos reductores de glucosa. Su mecanismo de acción implica estimular la liberación de insulina, inhibir la secreción de glucagón y ralentizar el vaciamiento gástrico, lo que contribuye en conjunto a mejorar los resultados metabólicos. Semaglutida también se asocia con un perfil de seguridad favorable, aunque puede tener efectos secundarios como trastornos gastrointestinales. Como fármaco péptido, está compuesto por 31 aminoácidos y tiene un peso molecular que refleja su estructura compleja. En general, Semaglutida representa un avance significativo en las opciones de tratamiento para la diabetes y la obesidad.
- Sermaglutide
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Encontrado 12 productos.
Semaglutide
CAS:Acylated GLP-1 analog with a half-life of 160 h. Semaglutide is under evaluation for the management of diabetes II. Due to its prolonged half-life, the peptide has to be injected only once per week. Bachem provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Bachem against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.Fórmula:C187H291N45O59Pureza:97.5%Forma y color:WhitePeso molecular:4113.64Ref: IN-DA00H230
1g569,00€2g906,00€5gA consultar5mg74,00€10mg108,00€25mg142,00€50mg163,00€100mg243,00€250mg363,00€500mg334,00€Semaglutide-d8 Tetratrifluoroacetate
CAS:Fórmula:C187H283D8N45O59·4C2HF3O2Forma y color:White To Off-White SolidPeso molecular:4121.69 4*114.02Semaglutide-d15 Tetratrifluoroacetate
CAS:Fórmula:C187H276D15N45O59·4C2HF3O2Peso molecular:4128.73 4*114.02Ref: 4Z-PS-189004
1mg2.180,00€5mgA consultar10mg7.280,00€25mg13.347,00€50mg21.840,00€100mgA consultarSemaglutide
CAS:Semaglutide is a glucagon-like peptide 1 receptor (GLP-1R) agonist(EC50 of 6.2 pM in a reporter assay using BHK cells expressing the human receptor).Fórmula:C187H291N45O59Pureza:96.92% - 99.78%Forma y color:SolidPeso molecular:4114Semaglutide
CAS:<p>Anti-diabetic and anti-obesity drug. We also have the heavy labelled material, CRB1301886.<br>Cymit Quimica provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Cymit Quimica against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.</p>Fórmula:C187H291N45O59Pureza:Min. 99.0 Area-%Forma y color:PowderPeso molecular:4,113.58 g/molSemaglutide sodium
CAS:<p>Cymit Quimica provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Cymit Quimica against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.</p>Fórmula:C187H291N45O59•NaxPureza:Min. 98.0 Area-%Forma y color:PowderPeso molecular:4,113.58 g/mol






